'Cancer Vaccines Will Not Replace Surgery or Chemo but Could Give Long-lasting Immunity'
Recent advances are bringing cancer vaccines much closer to reality, giving patients another weapon in their arsenal of cancer treatments, according to Dr Madiha Derouazi, CEO of Amal Therapeutics and one of three winners of the 2020 EU Prize for Women Innovators.
A Roadmap to Restore Science in Government Decisions
We do not have to live in a constant state of fear that our health is being put at-risk. We can restore and strengthen science-based decision-making processes that are protected from political interference. Today, we are releasing our first set of recommendations providing a roadmap for how the fede
There is a preprint with data on the first coronavirus vaccine candidate from the Pfizer/BioNTech effort. This article argues that it's extremely important that the human trial data is made available for the public to trust the vaccines that get approved.
How - and When - Can the Coronavirus Vaccine Become a Reality?
It is likely we'll eventually have a coronavirus vaccine - but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline Chen explains the tremendous challenges that lie ahead.
EPA Proposes Broad Science Restrictions in Midst of Coronavirus Pandemic
The Environmental Protection Agency moved today to restrict the types of research that can be used in public health protection decisions and scientific assessments. In the midst of the coronavirus pandemic, the agency is recklessly giving the public just 30 days to comment on this sweeping proposal.
What Coronavirus Teaches Us for Preventing the Next Big Bio Threat
The vast majority of the discourse among the punditry and policymakers is about ensuring we have the right response. Shouldn't we instead be asking a more fundamental question: How did this happen in the first place?